Zobrazeno 1 - 10
of 36
pro vyhledávání: '"ADAM N. BERMAN"'
Autor:
Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, David W. Biery, Rhanderson Cardoso, Sanjay Divakaran, Avinainder Singh, Daniel M. Huck, Brittany Weber, Jorge Plutzky, Christopher Cannon, Khurram Nasir, Marcelo F. Di Carli, James L. Januzzi, Deepak L. Bhatt, Ron Blankstein
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Diabetes mellitus (DM) and Lp(a) are well-established predictors of coronary artery disease (CAD) outcomes. However, their combined association remains poorly understood. Objective To investigate the relationship between elevated
Externí odkaz:
https://doaj.org/article/47e85525f26e4a1dbdccab413793377c
Autor:
Gurleen Kaur, Khaled Abdelrahman, Adam N. Berman, David W. Biery, Arthur Shiyovich, Daniel Huck, Michael Garshick, Ron Blankstein, Brittany Weber
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100641- (2024)
The strong association between lipoprotein (a) [Lp(a)] and atherosclerotic cardiovascular disease has led to considerations of Lp(a) being a potential target for mitigating residual cardiovascular risk. While approximately 20 % of the population has
Externí odkaz:
https://doaj.org/article/3d68ed3ce90242d38eadb78ff0433abb
Autor:
Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, David W. Biery, Gurleen Kaur, Sanjay Divakaran, Avinainder Singh, Daniel M. Huck, Brittany Weber, Jorge Plutzky, Marcelo F. Di Carli, Khurram Nasir, Christopher Cannon, James L. Januzzi, Deepak L. Bhatt, Ron Blankstein
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 10 (2024)
Background Lipoprotein (a) [Lp(a)] is a robust predictor of coronary heart disease outcomes, with targeted therapies currently under investigation. We aimed to evaluate the association of high Lp(a) with standard modifiable risk factors (SMuRFs) for
Externí odkaz:
https://doaj.org/article/f85d2353240d48e28b9e6216ffaadeed
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 7 (2024)
Background Many individuals eligible for statin therapy decline treatment, often due to fear of adverse effects. Misinformation about statins is common and drives statin reluctance, but its prevalence on social media platforms, such as Twitter (now X
Externí odkaz:
https://doaj.org/article/0884cfb7617c4ef3ba1cc3de5656eb17
Autor:
Gurleen Kaur, MD, Adam N. Berman, MD, David W. Biery, MD, Wanda Y. Wu, MD, Stephanie A. Besser, MS, Brittany Weber, MD, Marcelo Di Carli, MD, Deepak L. Bhatt, MD, Ron Blankstein, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100570- (2023)
Therapeutic Area: ASCVD/CVD in Women Background: Lipoprotein (a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, sex based differences in the association of Lp(a) with myocardial infarction (MI) have not been wel
Externí odkaz:
https://doaj.org/article/be9223a60a1d416096464e69bd477e2b
Autor:
Khaled Abdelrahman, Arthur Shiyovich, Daniel M. Huck, Adam N. Berman, Brittany Weber, Sumit Gupta, Rhanderson Cardoso, Ron Blankstein
Publikováno v:
Diagnostics, Vol 14, Iss 2, p 125 (2024)
Coronary artery calcium (CAC) is a marker of coronary atherosclerosis, and the presence and severity of CAC have been shown to be powerful predictors of future cardiovascular events. Due to its value in risk discrimination and reclassification beyond
Externí odkaz:
https://doaj.org/article/4a1ce8f959134f3fab89932360a3b376
Autor:
Adam N. Berman, Jason H. Wasfy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 13 (2022)
Externí odkaz:
https://doaj.org/article/2f59b4ea94db4d3492411c42dcccf59e
Autor:
HASAN K. Siddiqi, ERSILIA M. DEFILIPPIS, DAVID W. BIERY, AVINAINDER SINGH, WANDA Y. WU, SANJAY DIVAKARAN, ADAM N. BERMAN, THERESA RIZK, JAMES L. JANUZZI, ERIN BOHULA, GARRICK STEWART, MARCELO DI CARLI, DEEPAK L. BHATT, RON BLANKSTEIN
Publikováno v:
Journal of Cardiac Failure. 29:18-29
To investigate risk factors and outcomes of cardiogenic shock complicating acute myocardial infarction (AMI-CS) in young patients with AMI.AMI-CS is associated with high morbidity and mortality rates. Data regarding AMI-CS in younger individuals are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ce29e3dd1bb2b8493f337c353d0b91
https://doi.org/10.1016/j.cardfail.2022.08.012
https://doi.org/10.1016/j.cardfail.2022.08.012
Publikováno v:
Heart Rhythm. 20:69-75
Guidelines for anticoagulation in patients with atrial fibrillation (AF) aim to decrease the risk of ischemic stroke. However, there is a gap in actual practice between patients who have an indication for anticoagulation and those who are actually pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3df996aadf6ba1bc066a42f6403aa2
https://doi.org/10.1016/j.hrthm.2022.09.011
https://doi.org/10.1016/j.hrthm.2022.09.011
Autor:
Wanda Y. Wu, David W. Biery, Adam N. Berman, Grace Hsieh, Sanjay Divakaran, Sumit Gupta, Michael L. Steigner, Ayaz Aghayev, Hicham Skali, Donna M. Polk, Jorge Plutzky, Christopher P. Cannon, Marcelo F. Di Carli, Ron Blankstein
Publikováno v:
J Cardiovasc Comput Tomogr
BACKGROUND: Coronary artery calcium (CAC) scoring can identify individuals who may benefit from aggressive prevention therapies. However, there is a paucity of contemporary data on the impact of CAC testing on patient management. METHODS: Retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87f96aa91e622331896cf7b7e2d483e
https://doi.org/10.1016/j.jcct.2021.12.006
https://doi.org/10.1016/j.jcct.2021.12.006